AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Axogen, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$35.24+0.62 (+1.79%)
Close on Oct 19, 2026
- Market cap
- $1.88B
- P/E (TTM)
- –
- Dividend yield
- –
Axogen, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | % of revenue | YoY |
|---|---|---|---|---|---|
| United States | $222.44M | $184.25M | $156.21M | 98.8% | +20.7% |
| International | $2.77M | $3.09M | $2.80M | 1.2% | -10.2% |
From the segment and revenue-disaggregation notes of Axogen's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.